Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
Cost recovery, Gesetzliche Krankenversicherung, Pharmazeutisches Produkt, Staatliche Preispolitik, Kostendeckung, Deutschland, Public health insurance, Pharmaceutical, Price policy, Cost recovery, Germany, I18, ddc:330, Gesetzliche Krankenversicherung, L11, Wirtschaftswissenschaften, Pharmazeutisches Produkt, Staatliche Preispolitik, Kostendeckung, Germany, Pharmaceutical, Public health insurance, L51, Deutschland, Price policy, jel: jel:L51, jel: jel:L11, jel: jel:I18
Cost recovery, Gesetzliche Krankenversicherung, Pharmazeutisches Produkt, Staatliche Preispolitik, Kostendeckung, Deutschland, Public health insurance, Pharmaceutical, Price policy, Cost recovery, Germany, I18, ddc:330, Gesetzliche Krankenversicherung, L11, Wirtschaftswissenschaften, Pharmazeutisches Produkt, Staatliche Preispolitik, Kostendeckung, Germany, Pharmaceutical, Public health insurance, L51, Deutschland, Price policy, jel: jel:L51, jel: jel:L11, jel: jel:I18
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!